S32 Preventing and Reversing Obesity in Minority Children

Program: Symposia
Clinical Session
Saturday, April 2, 2016: 8:15 AM-9:45 AM
Room 205 (BCEC)
Chair:
Joan C Han, MD, University of Tennessee Health Science Center, Memphis, TN

Nothing to Disclose: JCH
8:15 AM
Melanie Cree-Green, MD, PhD, Department of Pediatrics, Section of Pediatric Endocrinology, Children's Hospital Colorado, Aurora, CO
Nothing to Disclose: MC
8:45 AM
Nefertiti H Durant, MD, MPH, FAAP, Department of Pediatrics, University of Alabama-Birmingham, Birmingham, AL
Nothing to Disclose: NHD
9:15 AM
Ilene Fennoy, MD, MPH, Pediatrics, Division of Pediatric Endocrinology, Columbia University Medical Center, New York, NY
Nothing to Disclose: IF
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire